Orasis Pharmaceuticals

Reshaping Vision Possibilities

Tel Aviv, Israel · Founded 2015 · $121.0M raised

Headquarters
Tel Aviv
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$121.0M
Last Round
$78.0M Growth EquityOct 2024
Rounds
3

About

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company focused on near vision correction. They developed Qlosi (pilocarpine hydrochloride 0.4%), a preservative-free prescription eye drop FDA-approved in 2023 for the treatment of presbyopia in adults. The company targets the nearly 128 million Americans living with age-related blurry near vision as an alternative to reading glasses or surgery.

Summary

Orasis Pharmaceuticals is a Healthcare company based in Tel Aviv, Israel, founded in 2015. It has raised $121.0M in total across 3 rounds, most recently a $78.0M Growth Equity round in Oct 2024. Investors include Visionary Ventures, Sequoia Capital and SBI Investment.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Growth EquityGrowth EquityOct 2024
$78.0M

Sign up to see all 3 rounds

Series B through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orasis Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/orasis-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/orasis-pharmaceuticals" alt="Orasis Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>